We sought to investigate and compare outcomes 2 years after Hybrid‐stenting with bioresorbable vascular scaffolds (BVS) and contemporary metallic drug‐eluting stents (DES) within the same coronary lesion versus BVS alone. Click to show full abstract
We sought to investigate and compare outcomes 2 years after Hybrid‐stenting with bioresorbable vascular scaffolds (BVS) and contemporary metallic drug‐eluting stents (DES) within the same coronary lesion versus BVS alone.
               
Click one of the above tabs to view related content.